Stefan Wöll

1.4k total citations
18 papers, 708 citations indexed

About

Stefan Wöll is a scholar working on Neurology, Cell Biology and Molecular Biology. According to data from OpenAlex, Stefan Wöll has authored 18 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 7 papers in Cell Biology and 5 papers in Molecular Biology. Recurrent topics in Stefan Wöll's work include Barrier Structure and Function Studies (7 papers), Skin and Cellular Biology Research (5 papers) and Cellular Mechanics and Interactions (4 papers). Stefan Wöll is often cited by papers focused on Barrier Structure and Function Studies (7 papers), Skin and Cellular Biology Research (5 papers) and Cellular Mechanics and Interactions (4 papers). Stefan Wöll collaborates with scholars based in Germany, Japan and Sweden. Stefan Wöll's co-authors include Rudolf E. Leube, Reinhard Windoffer, Uğur Şahin, Özlem Türeci, Pavel Strnad, Rita Mitnacht‐Kraus, Iréne Esposito, Karl Dhaene, Marc Roller and Anna Melissa Schlitter and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Cancer Research.

In The Last Decade

Stefan Wöll

18 papers receiving 701 citations

Peers

Stefan Wöll

NEURO

ONCOL

PRM

Boris Grin United States

Randi Schwimmer United States

Anne L. Pollack United States

Sharada Mokkapati United States

Suzanne M. Norvell United States

Chen Luxenburg Israel

Lorne Lonie United Kingdom

Gwynneth M. Edwards United Kingdom

Diana Miller United States

Tim C. Cao United States

Boris Grin United States

Stefan Wöll

538 ×1.7

472 ×1.9

35 ×0.2

NEURO

71 ×0.5

ONCOL

26 ×0.3

PRM

Citations per year, relative to Stefan Wöll Stefan Wöll (= 1×) peers Boris Grin

Countries citing papers authored by Stefan Wöll

Since Specialization

Citations

This map shows the geographic impact of Stefan Wöll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Wöll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Wöll more than expected).

Fields of papers citing papers by Stefan Wöll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Wöll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Wöll. The network helps show where Stefan Wöll may publish in the future.

Co-authorship network of co-authors of Stefan Wöll

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Wöll. A scholar is included among the top collaborators of Stefan Wöll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Wöll. Stefan Wöll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Laible, Mark, Stefan Wöll, Özlem Türeci, et al.. (2023). The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis. Journal of Translational Medicine. 21(1). 552–552. 17 indexed citations

Bähr-Mahmud, Hayat, Christiane Stadler, Claudia Lindemann, et al.. (2023). Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody. OncoImmunology. 12(1). 2255041–2255041. 16 indexed citations

Grimmler, Matthias, Christoph Hartmann, Tim Beißert, et al.. (2020). PLAC1 is essential for FGF7/FGFRIIIb-induced Akt-mediated cancer cell proliferation. Oncotarget. 11(20). 1862–1875. 10 indexed citations

Türeci, Özlem, Maria M. Kreuzberg, Korden Walter, et al.. (2018). Abstract 882: The anti-claudin 6 antibody, IMAB027, induces antibody-dependent cellular and complement-dependent cytotoxicity in claudin 6-expressing cancer cells. Cancer Research. 78(13_Supplement). 882–882. 5 indexed citations

Türeci, Özlem, Meike Wagner, Claudia Paret, et al.. (2018). Abstract 1907: Claudin 6 is a carcinoembryonic antigen with cancer stem cell marker features. Cancer Research. 78(13_Supplement). 1907–1907. 4 indexed citations

Türeci, Özlem, et al.. (2018). Characterization of zolbetuximab in pancreatic cancer models. OncoImmunology. 8(1). e1523096–e1523096. 80 indexed citations

Türeci, Özlem, Maria M. Kreuzberg, Korden Walter, et al.. (2018). Abstract 1778: Preclinical characterization of the safety and antitumor activity of IMAB027-vcMMAE, an anticlaudin 6 antibody-drug conjugate. Cancer Research. 78(13_Supplement). 1778–1778. 2 indexed citations

Heinz, C., Rita Mitnacht‐Kraus, Maria M. Kreuzberg, et al.. (2017). Preclinical evaluation of the anti-CLDN18.2 antibody, IMAB362, in pancreatic carcinoma. Annals of Oncology. 28. v125–v126. 6 indexed citations

Micke, Patrick, Johanna Sofia Margareta Mattsson, Karolina Edlund, et al.. (2014). Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non‐small‐cell lung cancer. International Journal of Cancer. 135(9). 2206–2214. 92 indexed citations

10.

Micke, Patrick, Karolina Edlund, Miriam Lohr, et al.. (2014). Abstract A37: Ectopic claudin 6 and 18.2 expression as potential treatment target in non-small cell lung cancer.. Clinical Cancer Research. 20(2_Supplement). A37–A37. 1 indexed citations

11.

Wöll, Stefan, Anna Melissa Schlitter, Karl Dhaene, et al.. (2013). Claudin 18.2 is a target for IMAB362 antibody in pancreatic neoplasms. International Journal of Cancer. 134(3). 731–739. 92 indexed citations

12.

Löffek, Stefanie, Stefan Wöll, Jörg Höhfeld, et al.. (2010). The ubiquitin ligase CHIP/STUB1 targets mutant keratins for degradation. Human Mutation. 31(4). 466–476. 39 indexed citations

13.

Wöll, Stefan, et al.. (2009). The Process-inducing Activity of Transmembrane Agrin Requires Follistatin-like Domains. Journal of Biological Chemistry. 285(5). 3114–3125. 17 indexed citations

14.

Wöll, Stefan, Reinhard Windoffer, & Rudolf E. Leube. (2007). p38 MAPK-dependent shaping of the keratin cytoskeleton in cultured cells. The Journal of Cell Biology. 177(5). 795–807. 83 indexed citations

15.

Windoffer, Reinhard, et al.. (2006). Focal adhesions are hotspots for keratin filament precursor formation. The Journal of Cell Biology. 173(3). 341–348. 78 indexed citations

16.

Wöll, Stefan, et al.. (2005). Clustering transmembrane-agrin induces filopodia-like processes on axons and dendrites. Molecular and Cellular Neuroscience. 31(3). 515–524. 38 indexed citations

17.

Wöll, Stefan, Reinhard Windoffer, & Rudolf E. Leube. (2005). Dissection of keratin dynamics: different contributions of the actin and microtubule systems. European Journal of Cell Biology. 84(2-3). 311–328. 49 indexed citations

18.

Windoffer, Reinhard, Stefan Wöll, Pavel Strnad, & Rudolf E. Leube. (2004). Identification of Novel Principles of Keratin Filament Network Turnover in Living Cells. Molecular Biology of the Cell. 15(5). 2436–2448. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact